Psychemedics Financial Statements From 2010 to 2024

PMD Stock  USD 2.66  0.09  3.50%   
Psychemedics financial statements provide useful quarterly and yearly information to potential Psychemedics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Psychemedics financial statements helps investors assess Psychemedics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Psychemedics' valuation are summarized below:
Gross Profit
9.3 M
Profit Margin
(0.19)
Market Capitalization
14.9 M
Enterprise Value Revenue
0.7388
Revenue
22.1 M
There are over one hundred nineteen available trending fundamental ratios for Psychemedics, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Psychemedics' recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 46.2 M. The current year's Enterprise Value is expected to grow to about 44.4 M

Psychemedics Total Revenue

20.81 Million

Check Psychemedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psychemedics main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 47 K or Total Revenue of 20.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.73, Dividend Yield of 0.0346 or PTB Ratio of 2.42. Psychemedics financial statements analysis is a perfect complement when working with Psychemedics Valuation or Volatility modules.
  
This module can also supplement various Psychemedics Technical models . Check out the analysis of Psychemedics Correlation against competitors.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.

Psychemedics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.1 M13.3 M19.2 M
Slightly volatile
Total Current Liabilities2.7 M4.7 M3.7 M
Slightly volatile
Total Stockholder Equity10.9 M6.7 M12.2 M
Pretty Stable
Property Plant And Equipment Net4.8 M4.9 M8.6 M
Pretty Stable
Cash3.4 MM3.8 M
Very volatile
Non Current Assets Total5.4 M6.5 M9.3 M
Slightly volatile
Cash And Short Term Investments1.9 MMM
Very volatile
Net Receivables3.6 M3.7 M4.6 M
Pretty Stable
Common Stock Shares Outstanding5.4 M5.7 M5.2 M
Slightly volatile
Liabilities And Stockholders Equity15.1 M13.3 M19.2 M
Slightly volatile
Non Current Liabilities Total1.8 M1.9 M3.3 M
Pretty Stable
Other Stockholder Equity23.3 M25 M22.9 M
Pretty Stable
Total Liabilities4.2 M6.6 M7.1 M
Slightly volatile
Total Current Assets9.7 M6.8 M9.9 M
Pretty Stable
Other Current Assets1.6 MMM
Slightly volatile
Short and Long Term Debt Total3.3 M2.3 M4.6 M
Pretty Stable
Other Current Liabilities1.6 M2.1 M2.1 M
Slightly volatile
Short Term Debt1.1 M1.4 M1.3 M
Pretty Stable
Accounts Payable601.5 K752 K697.8 K
Very volatile
Property Plant And Equipment Gross29.9 M28.5 M11.9 M
Slightly volatile
Common Stock Total Equity32.4 K27.9 K35.1 K
Slightly volatile
Common Stock31.5 K28.8 K35.2 K
Slightly volatile
Other Assets1.2 M1.7 M1.7 M
Slightly volatile
Property Plant Equipment6.2 M8.3 M8.9 M
Slightly volatile
Current Deferred Revenue261.4 K497.7 K340.4 K
Slightly volatile
Net Tangible Assets15.1 M12.4 M13.5 M
Pretty Stable
Capital Surpluse33.3 M37.7 M31.2 M
Slightly volatile
Deferred Long Term Liabilities877.6 K540 KM
Pretty Stable
Other Liabilities180.4 K189.9 K1.5 M
Slightly volatile
Long Term Debt Total2.3 M3.1 M3.5 M
Slightly volatile
Short and Long Term Debt289.8 K305 K937 K
Slightly volatile
Net Invested Capital12.6 MM18.5 M
Slightly volatile
Net Working CapitalM2.1 M7.5 M
Slightly volatile
Capital Stock34.5 K36.8 K31.7 K
Slightly volatile
Capital Lease Obligations2.7 MM3.3 M
Pretty Stable
Non Current Liabilities Other3.4 M4.5 M2.9 M
Slightly volatile

Psychemedics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.8 M2.7 M2.1 M
Slightly volatile
Interest Expense47 K49.5 K298.3 K
Pretty Stable
Total Revenue20.8 M22.1 M27.1 M
Pretty Stable
Other Operating Expenses18 M25 M24.2 M
Slightly volatile
Cost Of Revenue9.9 M13.7 M14.1 M
Slightly volatile
Total Operating Expenses8.1 M11.3 M10.1 M
Slightly volatile
Research Development857.2 K1.1 M1.2 M
Slightly volatile
Selling General Administrative6.2 M7.2 M5.4 M
Slightly volatile
Selling And Marketing Expenses2.8 MM191.8 M
Slightly volatile
Interest Income77.7 K52.2 K94.2 K
Slightly volatile
Reconciled Depreciation3.5 M2.9 MM
Slightly volatile
Net Interest Income34.4 K38.7 K42.1 K
Slightly volatile

Psychemedics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.4 M2.7 MM
Slightly volatile
Capital Expenditures151.1 K159 K1.5 M
Slightly volatile
End Period Cash Flow3.6 MMM
Very volatile
Begin Period Cash Flow3.6 M4.8 M4.1 M
Pretty Stable
Dividends Paid759 K799 K2.4 M
Slightly volatile
Stock Based Compensation862.6 K908 K6.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.730.76893.3905
Slightly volatile
Dividend Yield0.03460.0470.0405
Very volatile
PTB Ratio2.422.54654.3318
Slightly volatile
Days Sales Outstanding71.261.196769.4717
Pretty Stable
Book Value Per Share1.51.16242.2244
Very volatile
Invested Capital0.240.34440.4114
Slightly volatile
Average Payables524.8 K949.6 K882.3 K
Slightly volatile
Stock Based Compensation To Revenue0.0390.04110.29
Slightly volatile
PB Ratio2.422.54654.3318
Slightly volatile
EV To Sales0.740.7843.1152
Slightly volatile
Inventory Turnover23.6539.1940.5873
Very volatile
Days Of Inventory On Hand0.00.05.1953
Slightly volatile
Payables Turnover15.7718.198122.1111
Slightly volatile
Sales General And Administrative To Revenue0.30.32550.211
Slightly volatile
Average Inventory0.550.57110.9 K
Slightly volatile
Research And Ddevelopement To Revenue0.02660.05180.0417
Pretty Stable
Cash Per Share0.570.34220.7613
Very volatile
Days Payables Outstanding27.8220.05723.1709
Slightly volatile
Current Ratio1.371.44512.6033
Slightly volatile
Tangible Book Value Per Share1.51.16242.2244
Very volatile
Receivables Turnover4.925.96445.9274
Pretty Stable
Graham Number3.544.35055.2979
Pretty Stable
Shareholders Equity Per Share1.51.16242.2244
Very volatile
Debt To Equity0.240.34440.4114
Slightly volatile
Average Receivables2.9 M4.6 M4.8 M
Pretty Stable
Revenue Per Share2.923.84984.9038
Very volatile
Debt To Assets0.140.17320.2195
Slightly volatile
Operating Cycle81.161.196772.4281
Slightly volatile
Price Book Value Ratio2.422.54654.3318
Slightly volatile
Days Of Payables Outstanding27.8220.05723.1709
Slightly volatile
Ebt Per Ebit1.741.1775.7172
Pretty Stable
Company Equity Multiplier1.121.98891.5614
Slightly volatile
Long Term Debt To Capitalization0.140.12410.1968
Pretty Stable
Total Debt To Capitalization0.170.25620.2773
Slightly volatile
Debt Equity Ratio0.240.34440.4114
Slightly volatile
Quick Ratio1.141.20392.3245
Slightly volatile
Net Income Per E B T0.81.20830.7751
Slightly volatile
Cash Ratio0.40.41711.0073
Slightly volatile
Cash Conversion Cycle54.8741.139754.5775
Pretty Stable
Days Of Inventory Outstanding0.00.05.1953
Slightly volatile
Days Of Sales Outstanding71.261.196769.4717
Pretty Stable
Price To Book Ratio2.422.54654.3318
Slightly volatile
Fixed Asset Turnover7.284.51993.9449
Very volatile
Debt Ratio0.140.17320.2195
Slightly volatile
Price Sales Ratio0.730.76893.3905
Slightly volatile
Asset Turnover1.111.66531.3317
Very volatile
Price Fair Value2.422.54654.3318
Slightly volatile

Psychemedics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap46.2 M24.8 M40.4 M
Slightly volatile
Enterprise Value44.4 M23.8 M39.1 M
Slightly volatile

Psychemedics Fundamental Market Drivers

Cash And Short Term InvestmentsM

Psychemedics Upcoming Events

19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Psychemedics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Psychemedics income statement, its balance sheet, and the statement of cash flows. Psychemedics investors use historical funamental indicators, such as Psychemedics's revenue or net income, to determine how well the company is positioned to perform in the future. Although Psychemedics investors may use each financial statement separately, they are all related. The changes in Psychemedics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Psychemedics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Psychemedics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Psychemedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue497.7 K261.4 K
Total Revenue22.1 M20.8 M
Cost Of Revenue13.7 M9.9 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.33  0.30 
Research And Ddevelopement To Revenue 0.05  0.03 
Capex To Revenue(0.01)(0.01)
Revenue Per Share 3.85  2.92 
Ebit Per Revenue(0.13)(0.13)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Psychemedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Psychemedics' short interest history, or implied volatility extrapolated from Psychemedics options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Psychemedics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports:
Check out the analysis of Psychemedics Correlation against competitors.
For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Psychemedics Stock analysis

When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Dividend Share
0.07
Earnings Share
(0.72)
Revenue Per Share
3.85
Quarterly Revenue Growth
(0.12)
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.